Morgan Stanley Iridex Corp Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
A detailed history of Morgan Stanley transactions in Iridex Corp stock. As of the latest transaction made, Morgan Stanley holds 1,000 shares of IRIX stock, worth $1,740. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$1,740% of portfolio
0.0%Shares
13 transactions
Others Institutions Holding IRIX
# of Institutions
31Shares Held
3.3MCall Options Held
500Put Options Held
33.5K-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX1MShares$1.74 Million3.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA561KShares$976,3070.0% of portfolio
-
Amh Equity LTD501KShares$871,9501.21% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny397KShares$691,4060.0% of portfolio
-
Geode Capital Management, LLC Boston, MA131KShares$228,2390.0% of portfolio
About IRIDEX CORP
- Ticker IRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 15,985,600
- Market Cap $27.8M
- Description
- IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...